FibroGen, Inc. (FGEN) is now among the bigger bargains in its industry.
Within the last year the price ranged from $32.34 – 61.23 and there is a wide opportunity to get in. Its next earnings report will be released on Feb 26, 2020.
move, based on 6 analysts offering 12 month price targets for Epizyme in the last 3 months. The average price target is $20.33 with a high forecast of $25.00 and a low forecast of $16.00. The average price target represents a -22.26% decrease from the last price of $26.15.
Analysts like Yaron Werber from Cowen & Co. believe that we could see stock price minimum $18.00.
Another prominent analyst, Andrew Berens of Leerink Partners rates EPZM as a Buy. The rating was made just 9 days ago.
Epizyme, Inc.(EPZM) Recent News Reports
On average 0.0 articles are written each week about EPZM but this week 0 articles were written and they were 68% Bullish and 32% Bearish.
Epizyme, Inc. Target Levels
The market experts are predicting that EPZM is a Strong Buy. Some other stocks to consider in this sector are: